Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

The increasing prevalence of heart failure (HF) has led to advancements in therapeutic strategies, including the development of new pharmacological treatments and the expansion of guideline recommendations across the spectrum of left ventricular ejection fractions.

Heart Failure 52

Heart Failure Heart Transplant Pharmacology Transplant 52

Journal of Clinical Investigation - Cardiology

SEPTEMBER 3, 2024

We discuss salivary gland anatomy and physiology to understand how anticancer therapies such as chemotherapy, bone marrow transplantation, immunotherapy, and radiation therapy impair salivary function. Emerging approaches, including cellular and gene therapy and novel pharmacologic approaches, are described.

Cancer 95

Cancer Quality of Life Anatomy Pharmacology 95

DAIC

FEBRUARY 2, 2024

Optional Pre-conference Workshop to be held Friday afternoon includes a number of topics: Pharmacology 101 Pharmacology 101 – Workshop: Alana Ferrari, PharmD, BCOP How Do I Grow My Career in Cardio-Oncology? An overview of sessions, focus topics and presenters follows. Friday, February 9 Registration (1:00 - 6:00 p.m.)

Cardio Oncology 95

Cardio Oncology Cancer Pharmacology RN 95

Circulation

DECEMBER 17, 2024

We explored the mechanism of METTL4 involvement in atherosclerosis usingMettl4Mac-KO-Apoe-/-andMettl4MUT-Apoe-/-mice and cell models, as well as bone marrow transplantation. Natural compound libraries were screened to identify potent METTL4 antagonists.

Atherosclerosis 40

Atherosclerosis Transplant Plaque Pharmacology 40

Journal of Cardiovascular Pharmacology

SEPTEMBER 4, 2023

Finally, emerging therapies in CKD such as IL-6 inhibition, small-interfering RNA against lipoproteins, AhR inhibitors, and therapies adopted from the renal transplant population including mTOR inhibitors and T regulatory cell promoters may have benefits for cardiorenal and inflammatory endpoints but require further investigation in clinical trials.

Kidney Disease 40

Kidney Disease Transplant Atherosclerosis Biomarkers 40

Journal of Clinical Investigation - Cardiology

JUNE 3, 2024

Neuroinflammation is a recognized complication of immunotherapeutic approaches such as immune checkpoint inhibitor treatment, chimeric antigen receptor therapy, and graft versus host disease (GVHD) occurring after allogeneic hematopoietic stem cell transplantation.

Pharmacology 98

Pharmacology Transplant 98

Cardiometabolic Health Congress

MAY 3, 2024

His contributions significantly shaped the current state of hepatology and the broader scientific community, evidenced by his role as an associate editor of Hepatology and Alimentary Pharmacology and Therapeutics and as a peer reviewer for over 20 prestigious medical journals. Reau, MD, FAASLD, AGAF , Richard B.

Research 59

Research Education Pharmacology Transplant 59